New therapies and new goals for psoriatic arthritis

Arthritis Rheum. 2011 Apr;63(4):874-6. doi: 10.1002/art.30173.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Abatacept
  • Antirheumatic Agents / pharmacology
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Psoriatic / drug therapy*
  • Arthritis, Psoriatic / pathology
  • CD4-Positive T-Lymphocytes / drug effects
  • CD4-Positive T-Lymphocytes / pathology
  • CD8-Positive T-Lymphocytes / drug effects
  • CD8-Positive T-Lymphocytes / pathology
  • Humans
  • Immunoconjugates / pharmacology
  • Immunoconjugates / therapeutic use*
  • Magnetic Resonance Imaging
  • Outcome Assessment, Health Care*
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Antirheumatic Agents
  • Immunoconjugates
  • Abatacept